バイオシミュレーションの世界市場...市場調査レポートについてご紹介

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 24)

4 Premium Insights (Page No. – 28)
4.1 Lucrative Opportunities in the Global Biosimulation Market
4.2 Life Cycle Analysis, By Region (2015–2020)

5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Application
5.2.3 By End User
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Growth in the Pharmaceutical and Biotechnology Industries
5.3.1.2 Increase in R&D Investments in the Pharmaceutical and Biotechnology Industries
5.3.1.3 Technological Advancements
5.3.1.4 Need to Curtail Drug Discovery and Development Costs
5.3.1.5 Growth in the Biologics and Biosimilars Market and Increased Use of Personalized Medicines
5.3.2 Restraints
5.3.2.1 Lack of Standardization
5.3.2.2 Lack of Trained Professionals
5.3.3 Opportunities
5.3.3.1 Emerging Applications
5.3.4 Challenges
5.3.4.1 Limited Knowledge of Biological Systems and Processes
5.3.5 Trends
5.3.5.1 Collaborations of Universities and Research Labs With Suppliers

6 Biosimulation Market, By Product (Page No. – 42)
6.1 Introduction
6.2 Software
6.2.1 PK/PD Modeling and Simulation Software
6.2.2 Molecular Modeling and Simulation Software
6.2.3 Pbpk Modeling and Simulation Software
6.2.4 Toxicity Prediction Software
6.2.5 Trial Design Software
6.2.6 Other Software
6.3 Services
6.3.1 In-House Services
6.3.2 External/Contract Services

7 Biosimulation Market, By Application (Page No. – 55)
7.1 Introduction
7.2 Drug Development
7.2.1 Preclinical Testing
7.2.1.1 PK/PD
7.2.1.2 ADME/TOX
7.2.2 Clinical Trials
7.3 Drug Discovery
7.3.1 Target Identification and Validation
7.3.2 Lead Identification and Optimization
7.4 Other Applications

8 Biosimulation Market, By End User (Page No. – 70)
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Academic and Government Research Institutes
8.4 Contract Research Organizations
8.5 Regulatory Authorities
8.6 Other End Users

9 Global Biosimulation Market, By Region (Page No. – 81)
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 108)
10.1 Introduction
10.2 Strategic Overview
10.3 Leading Players in the Biosimulation Market
10.4 Competitive Situation and Trends
10.4.1 Product Upgradation
10.4.2 Agreements, Collaborations, Expansions, and Partnerships
10.4.3 New Product and Service Launches
10.4.4 Acquisitions
10.4.5 Other Developments

11 Company Profiles (Page No. – 116)
11.1 Introduction
11.2 Certara USA, Inc.
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Simulation Plus Inc.
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Dassault Systèmes SA
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.4.4 MnM View
11.5 Schrödinger Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.5.4 MnM View
11.6 Advanced Chemistry Development, Inc.
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments
11.6.4 MnM View
11.7 Chemical Computing Group, Inc.
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.8 Entelos Holding Corporation
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.8.4 MnM View
11.9 Genedata Ag
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.9.4 MnM View
11.10 Physiomics PLC
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.10.4 MnM View
11.11 Rhenovia Pharma Ltd.
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments
11.11.4 MnM View

12 Appendix (Page No. – 135)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports